Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 0.6999
-6.62 %
$ 61.3 M
Market Cap
-1.41
P/E
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.[ Read More ]
The intrinsic value of one BEATW stock under the base case scenario is HIDDEN Compared to the current market price of 0.7 USD, HeartBeam, Inc. is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart BEATW
FINANCIALS
0
REVENUE
-15.3 M
OPERATING INCOME
-14.6 M
NET INCOME
-12.1 M
OPERATING CASH FLOW
-256 K
INVESTING CASH FLOW
25 M
FINANCING CASH FLOW
0
REVENUE
-5.07 M
OPERATING INCOME
-4.98 M
NET INCOME
-3.31 M
OPERATING CASH FLOW
-103 K
INVESTING CASH FLOW
21 K
FINANCING CASH FLOW
Balance Sheet Decomposition
HeartBeam, Inc.
| Current Assets | 16.8 M |
| Cash & Short-Term Investments | 16.2 M |
| Receivables | 0 |
| Other Current Assets | 636 K |
| Non-Current Assets | 306 K |
| Long-Term Investments | 0 |
| PP&E | 256 K |
| Other Non-Current Assets | 50 K |
| Current Liabilities | 1.19 M |
| Accounts Payable | 0 |
| Short-Term Debt | 0 |
| Other Current Liabilities | 1.19 M |
| Non-Current Liabilities | 0 |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
HeartBeam, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 15.3 M |
| Operating Income | -15.3 M |
| Other Expenses | -675 K |
| Net Income | -14.6 M |
RATIOS
0.00%
GROSS MARGIN
0.00%
OPERATING MARGIN
0.00%
NET MARGIN
-91.86%
ROE
-85.45%
ROA
-96.09%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
HeartBeam, Inc.
| Net Income | -14.6 M |
| Depreciation & Amortization | 15.3 M |
| Capital Expenditures | -256 K |
| Stock-Based Compensation | 3.21 M |
| Change in Working Capital | -662 K |
| Others | -191 K |
| Free Cash Flow | -12.3 M |
Wall Street Analysts Price Targets
HeartBeam, Inc.
BEATW has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00%
DIVIDEND YIELD
0 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
HeartBeam, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
1 year ago
Sep 29, 2023
|
Sell 11.3 K USD
|
de Urioste George
Director |
- 5500
|
2.06 USD |
|
1 year ago
Sep 27, 2023
|
Sell 3.87 K USD
|
de Urioste George
Director |
- 1834
|
2.11 USD |
|
1 year ago
Sep 28, 2023
|
Sell 16.3 K USD
|
de Urioste George
Director |
- 8000
|
2.04 USD |
|
1 year ago
Sep 22, 2023
|
Sell 5.29 K USD
|
de Urioste George
Director |
- 2393
|
2.21 USD |
|
1 year ago
Sep 26, 2023
|
Sell 10.4 K USD
|
de Urioste George
Director |
- 5000
|
2.09 USD |
|
1 year ago
Sep 20, 2023
|
Sell 2.17 K USD
|
de Urioste George
Director |
- 883
|
2.46 USD |
|
1 year ago
Sep 21, 2023
|
Sell 241 USD
|
de Urioste George
Director |
- 100
|
2.41 USD |
|
1 year ago
Sep 15, 2023
|
Sell 10.4 K USD
|
de Urioste George
Director |
- 4269
|
2.43 USD |
|
1 year ago
Sep 18, 2023
|
Sell 12.3 K USD
|
de Urioste George
Director |
- 5000
|
2.46 USD |
|
1 year ago
Sep 13, 2023
|
Sell 3.57 K USD
|
de Urioste George
Director |
- 1878
|
1.9 USD |
|
1 year ago
Sep 13, 2023
|
Sell 6.09 K USD
|
de Urioste George
Director |
- 3122
|
1.95 USD |
|
1 year ago
Sep 14, 2023
|
Sell 10.8 K USD
|
de Urioste George
Director |
- 5000
|
2.17 USD |
|
2 years ago
Dec 30, 2021
|
Bought 0 USD
|
Vajdic Branislav
Chief Executive Officer |
+ 25000
|
0 USD |
|
2 years ago
Dec 30, 2021
|
Bought 0 USD
|
Vajdic Branislav
Chief Executive Officer |
+ 25000
|
0 USD |
|
2 years ago
Dec 21, 2021
|
Bought 0 USD
|
Elfrink Willhem
Director |
+ 10000
|
0 USD |
|
2 years ago
Dec 21, 2021
|
Bought 16.8 K USD
|
BROUNSTEIN RICHARD D
Chief Financial Officer |
+ 5000
|
3.3692 USD |
|
3 years ago
Nov 11, 2021
|
Bought 30 K USD
|
BROUNSTEIN RICHARD D
CHIEF FINANCIAL OFFICER |
+ 5000
|
5.99 USD |
|
3 years ago
Nov 11, 2021
|
Bought 53.9 K USD
|
Ortigas-Wedekind Marga
Director |
+ 9000
|
5.99 USD |
7. News
8. Profile Summary
HeartBeam, Inc. BEATW
COUNTRY
US
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 61.3 M
Dividend Yield
0.00%
Description
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Contact
None
IPO Date
None
Employees
15
Officers
Mr. Richard M. Ferrari
Executive Chairman
Dr. Branislav Vajdic Ph.D.
Founder, Chief Executive Officer & Director
Dr. Peter J. Fitzgerald FACC, M.D., Ph.D.
Chief Medical Officer
Mr. Robert P. Eno
Pres
Mr. Richard D. Brounstein
Chief Financial Officer & Treasurer
Mr. Kenneth Persen
Chief Technology Officer